Cleveland Clinic reports world’s first transcontinental robot-assisted focal therapy procedure for prostate cancer

Exciting news for robot-assisted therapy!

The Cleveland Clinic’s recent success with the world’s first transcontinental robot-assisted focal therapy for prostate cancer marks a groundbreaking moment in digital health and surgical robotics. Using EDAP Technomed’s Focal One Robotic HIFU system, a urologist in Cleveland precisely ablated a tumor in a patient located over 7,000 miles away in Abu Dhabi—without any complications. 

This advanced system combines high-intensity focused ultrasound with real-time MRI and 3D biopsy data, enabling submillimetric accuracy and reduced side effects compared to traditional treatments. Its remote capabilities open doors for global access to specialized care, revolutionizing how and where complex procedures can be delivered.

As medical technologies grow more connected and sophisticated, Intertek offers critical support to innovators by providing rigorous safety, performance, and cybersecurity testing, along with regulatory guidance. With decades of experience in medical device compliance and access to global markets, Intertek ensures cutting-edge solutions like robotic HIFU systems meet the highest standards—accelerating safe adoption worldwide.

Learn more about how Intertek can help: https://www.intertek.com/medical/